Moreover, tumours predicted to respond based on PD-L1 staining are seldom predicted to respond based on TMB analysis, suggesting that there are multiple factors determining response and currently approved approaches do not cover the whole spectrum of response or resistance determinants [89, 90]. This evidence concerns the gene CD274 and neoplasm.